Beta Drugs Share Price
₹1,889.00 -6.05 (-0.32%)
22 Jan, 2025 12:09
Start SIP in BETA
Start SIPPerformance
- Low
- ₹1,850
- High
- ₹1,903
- 52 Week Low
- ₹1,060
- 52 Week High
- ₹2,326
- Open Price₹1,900
- Previous Close₹1,895
- Volume1,800
Investment Returns
- Over 1 Month -8.3%
- Over 3 Month + 4.53%
- Over 6 Month + 45.25%
- Over 1 Year + 32.56%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 49.8
- PEG Ratio
- -
- Market Cap Cr
- 1,816
- P/B Ratio
- 10
- Average True Range
- 88.18
- EPS
- 37.9
- Dividend Yield
- 0
- MACD Signal
- -43.96
- RSI
- 43.07
- MFI
- 38.84
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,889.00
-6.05
(-0.32%)
- Bearish Moving Average 12
- Bullish Moving Average 4
- 20 Day
- ₹1,962.19
- 50 Day
- ₹1,986.38
- 100 Day
- ₹1,887.85
- 200 Day
- ₹1,691.87
Resistance and Support
1913.37
- R3 1,986.63
- R2 1,968.32
- R1 1,931.68
- S1 1,876.73
- S2 1,858.42
- S3 1,821.78
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-06 | Quarterly Results | |
2024-10-19 | To consider Fund Raising | |
2024-05-14 | Audited Results | |
2023-11-07 | Quarterly Results & Others | To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE. |
2023-05-08 | Audited Results |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Beta Drugs FAQs
Beta Drugs share price is ₹1,889 As on 22 January, 2025 | 11:55
The Market Cap of Beta Drugs is ₹1816.1 Cr As on 22 January, 2025 | 11:55
The P/E ratio of Beta Drugs is 49.8 As on 22 January, 2025 | 11:55
The PB ratio of Beta Drugs is 10 As on 22 January, 2025 | 11:55
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.